Ohmagari Norio, Kurai Hanako, Yamagishi Yuka, Mikamo Hiroshige
Disease Control and Prevention Center, National Center for Global Health and Medicine, Aichi Medical University Graduate School of Medicine, Nagakute, Aichi, Japan; Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, Nagakute, Aichi, Japan.
Division of Infectious Diseases, Shizuoka Cancer Center, Aichi Medical University Graduate School of Medicine, Nagakute, Aichi, Japan.
Am J Infect Control. 2014 Jul;42(7):739-43. doi: 10.1016/j.ajic.2014.04.003.
The emergence of multi-drug-resistant gram-negative rods (MDR-GNRs) has become a worldwide problem. To limit the emergence of MDR-GNRs, a tertiary care cancer center in Japan implemented a policy that requires the pre-emptive isolation of patients with organisms that have the potential to be MDR-GNRs.
A retrospective analysis was performed. Any gram-negative bacillus isolates categorized as intermediate or resistant to at least 2 classes of antimicrobials were subjected to contact precautions. The incidence of patients with MDR-GNRs was analyzed.
There was no difference between the preintervention and intervention time periods in the detection rate of nonfermenting MDR-GNR species (0.15 per 10,000 vs 0.35 per 10,000 patient-days, P = .08). There was an increase in the detection rate of multi-drug-resistant Enterobacteriaceae (0.19 per 10,000 vs 0.56 per 10,000 patient-days, P = .007), which was prominent for extended-spectrum β-lactamase (ESBL)-producing organisms (0.19 per 10,000 vs 0.50 per 10,000 patient-days, P = .02).
Our intervention kept the emergence of multi-drug-resistant non-glucose-fermenting gram-negative bacilli to a small number, but it failed to prevent an increase in ESBL producers. Policies, such as active detection and isolation, are warranted to decrease the incidence of these bacilli.
多重耐药革兰氏阴性菌(MDR - GNRs)的出现已成为一个全球性问题。为限制MDR - GNRs的出现,日本一家三级护理癌症中心实施了一项政策,要求对有可能是MDR - GNRs的病原体携带者进行先发隔离。
进行回顾性分析。将任何归类为对至少两类抗菌药物呈中介或耐药的革兰氏阴性杆菌分离株采取接触预防措施。分析MDR - GNRs患者的发生率。
在非发酵型MDR - GNRs菌种的检出率方面,干预前和干预期间没有差异(每10000人日分别为0.15和0.35,P = 0.08)。多重耐药肠杆菌科的检出率有所增加(每10000人日分别为0.19和0.56,P = 0.007),这在产超广谱β - 内酰胺酶(ESBL)的菌株中尤为突出(每10000人日分别为0.19和0.50,P = 0.02)。
我们的干预措施使多重耐药非葡萄糖发酵革兰氏阴性杆菌的出现保持在少数,但未能阻止产ESBL菌株的增加。有必要采取主动检测和隔离等政策来降低这些杆菌的发生率。